Segment Reporting (Tables)

12 Months Ended

Jun. 30, 2025

Statements [Line Items]

Disclosure of Operating Segment Information

Operating segment information June 30, 2025	Immunotherapy A$			Unallocated A$		Consolidated A$
Revenue
License revenue		—			—		—
Other income
Research material sales		59,709			—		59,709
Grant income		4,974,823			—		4,974,823
Miscellaneous income		—			390		390
Net change on fair value movement		—			9,242		9,242
Interest income		—			5,287,209		5,287,209
Total revenue and other income		5,034,532			5,296,841		10,331,373
Result
Segment Result		(65,020,504	)		3,586,339		(61,434,165	)
Profit/(loss) before income tax expense		(65,020,504	)		3,586,339		(61,434,165	)
Income tax expense		—			—		—
Loss after income tax expense							(61,434,165	)
Total segment assets		156,983,434			—		156,983,434
Total segment liabilities		13,348,071			—		13,348,071

Operating segment information June 30, 2024	Immunotherapy A$			Unallocated A$		Consolidated A$
Revenue
License revenue		—			—		—
Other income
Research material sales		119,089			—		119,089
Grant income		3,722,788			—		3,722,788
Net gain on fair value movement of warrants		—			—		—
Net gain on foreign exchange		—			113,458		113,458
Interest income		—			3,882,757		3,882,757
Total revenue and other income		3,841,877			3,996,215		7,838,092
Result
Segment Result		(46,556,929	)		3,840,304		(42,716,625	)
Profit/(loss) before income tax expense		(46,556,929	)		3,840,304		(42,716,625	)
Income tax expense		—			—		—
Loss after income tax expense							(42,716,625	)
Total segment assets		201,579,281			—		201,579,281
Total segment liabilities		12,057,539			—		12,057,539

Operating segment information June 30, 2023	Immunotherapy A$			Unallocated A$		Consolidated A$
Revenue
License revenue		—			—		—
Other income
Research material sales		191,721			—		191,721
Grant income		3,314,001			—		3,314,001
Net gain on fair value movement of warrants		—			131,896		131,896
Net gain on foreign exchange		—			623,511		623,511
Interest income		—			938,999		938,999
Total revenue and other income		3,505,722			1,694,406		5,200,128
Result
Segment Result		(41,431,305	)		1,534,957		(39,896,348	)
Profit/(loss) before income tax expense		(41,431,305	)		1,534,957		(39,896,348	)
Income tax expense		—			—		—
Loss after income tax expense							(39,896,348	)
Total segment assets		147,448,990			—		147,448,990
Total segment liabilities		10,979,601			—		10,979,601